Purchase Order 36C24E24P0114
Award Date
9/30/24
Potential Completion Date
9/29/25
Potential Value
$68K
Funding Federal Agency
Veterans Integrated Service Network 7
Contracting Federal Agency
Veterans Integrated Service Network 4
Awardee
Tempus AI, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60654, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
The Department of Veterans Affairs (VA) Headquarters awarded a firm fixed price delivery order contract to Akesogen, Inc.'s Tempus Labs, Inc. division, a for-profit technology company that provides genomic sequencing and analysis services. The $13,020,379.40 contract tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services to support the VA's biomedical research programs,...
This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...
This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Akesogen, Inc.'s Tempus Labs division for DNA extraction services. The $5,286.10 firm-fixed-price purchase order does not have a set-aside designation. Tempus Labs is a for-profit technology company that specializes in advanced genomic analysis services, primarily supporting large-scale biomedical research programs conducted by federal agencies like the Department of...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $6,049,896.00 Firm Fixed Price Delivery Order contract to Akesogen, Inc. Tempus Labs, Inc. Division for genomic sequencing and analysis services. This contract, which does not have a set-aside designation, is in support of the VA's biomedical research programs, including the Million Veteran Program research initiative. Akesogen, Inc. Tempus Labs, Inc. Division has previously held delivery order contracts with the VA...
This is a definitive, time and materials contract awarded by the National Institutes of Health (NIH) to Tempus AI, Inc., a for-profit technology company specializing in precision medicine and advanced genomic sequencing services. The contract, valued at $60,565,809.84, is for ADAPT CRO Support Services and does not have a set-aside designation. The contract has an ultimate completion date of September 17, 2030 and was awarded on September 18, 2025. Tempus AI, Inc., also doing business as...